Literature DB >> 7178534

Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay.

P N Maton, A C Selden, V S Chadwick.   

Abstract

Defining the role of cholecystokinin (CCK) in gut physiology and disease has proved difficult because of problems with development of radioimmunoassays and because CCK exists in several different molecular forms which have different biological actions. In order to measure small (8 amino acid residues, CCK 8) and large (33 and 39 residues) forms of CCK in plasma we have developed high pressure liquid chromatographic (HPLC) fractionation of plasma prior to radioimmunoassay. Fasting plasma CCK 8 and CCK 33/39 levels were usually undetectable (less than 3 and less than 6 pmol/1, respectively). After a liquid fat meal both CCK 8 and CCK 33/39 levels were significantly elevated at 5 min (11.3 +/- 3.3 and 11.6 +/- 2.6 pmol/1, respectively). Peak CCK 8 levels occurred at 30 min (15.0 +/- 4.4 pmol/1) while peak CCK 33/39 levels occurred at 120 min (16.7 +/- 4.9 pmol/1). Total CCK levels showed a biphasic response to the meal. These CCK 8 and CCK 33/39 responses to oral fat are consistent with a role for these hormones in the regulation of gallbladder emptying and pancreatic secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7178534     DOI: 10.1016/0167-0115(82)90118-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

1.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

2.  Plasma concentrations of cholecystokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK.

Authors:  A Lindén; M Carlquist; S Hansen; K Uvnäs-Moberg
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

3.  Plasma cholecystokinin response to oral fat in patients with Billroth I and Billroth II gastrectomy.

Authors:  W P Hopman; J B Jansen; C B Lamers
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

4.  Release of cholecystokinin and gallbladder contraction before and after gastrectomy.

Authors:  K Inoue; A Fuchigami; R Hosotani; M Kogire; Y S Huang; T Miyashita; T Suzuki; K Tsuda; Y Seino; P L Rayford
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

5.  Influence of various nutrients and their mode of application on plasma cholecystokinin (CCK) bioactivity.

Authors:  J Mössner; M Grumann; J Zeeh; W Fischbach
Journal:  Clin Investig       Date:  1992-02

6.  Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.

Authors:  J B Jansen; W P Hopman; C B Lamers
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

7.  Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.

Authors:  T Sakamoto; M Fujimura; J Newman; X G Zhu; G H Greeley; J C Thompson
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.